{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:20:20Z","timestamp":1759940420986,"version":"3.41.2"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA008748","R01 CA236615-01","R01 AI 060866","R01 AI 084178","R56 AI 122376"],"award-info":[{"award-number":["P30 CA008748","R01 CA236615-01","R01 AI 060866","R01 AI 084178","R56 AI 122376"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["CA 170630","BC132124","CA180889","LC160212"],"award-info":[{"award-number":["CA 170630","BC132124","CA180889","LC160212"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001755","name":"Mesothelioma Applied Research Foundation","doi-asserted-by":"publisher","award":["549976","Craig Kozicki Memorial grant"],"award-info":[{"award-number":["549976","Craig Kozicki Memorial grant"]}],"id":[{"id":"10.13039\/100001755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004436","name":"Commonwealth Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007052","name":"Memorial Sloan-Kettering Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.01042","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T15:16:37Z","timestamp":1570806997000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Globular C1q Receptor (gC1qR\/p32\/HABP1) Is Overexpressed in Malignant Pleural Mesothelioma and Is Associated With Increased Survival in Surgical Patients Treated With Chemotherapy"],"prefix":"10.3389","volume":"9","author":[{"given":"Xiaoyu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania G.","family":"Aly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navin K.","family":"Chintala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kay See","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjorie G.","family":"Zauderer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine R.","family":"Dembitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Beth","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berhane","family":"Ghebrehiwet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasad S.","family":"Adusumilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellinor I. B.","family":"Peerschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0162-3109(00)80301-X","article-title":"C1q: structure, function, and receptors","volume":"49","author":"Kishore","year":"2000","journal-title":"Immunopharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1084\/jem.20042251","article-title":"Defective B cell tolerance checkpoints in systemic lupus erythematosus","volume":"201","author":"Yurasov","year":"2005","journal-title":"J Exp Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"7581","DOI":"10.4049\/jimmunol.178.12.7581","article-title":"A novel role of complement factor C1q in augmenting the presentation of antigen captured in immune complexes to CD8+ T lymphocytes","volume":"178","author":"Van Montfoort","year":"2007","journal-title":"J Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.4049\/jimmunol.175.7.4706","article-title":"gC1q receptor ligation selectively down-regulated human IL-2 production through activation of the phosphoinositide 3-kinase pathway","volume":"175","author":"Waggoner","year":"2005","journal-title":"J Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1172\/JCI10323","article-title":"Interaction between the complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation","volume":"106","author":"Kittlesen","year":"2000","journal-title":"J Clin Invest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"43479","DOI":"10.1074\/jbc.M407640200","article-title":"Hepatitis C virus core selectively suppresses interleukin 12-synthesis in human macrophages by interfering with AP-1 activation","volume":"279","author":"Eisen-Vandervelde","year":"2004","journal-title":"J Biol Chem"},{"key":"B7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0171-2985(98)80029-6","article-title":"Structure and Function of gC1q-R: a multiligand binding cellular protein","volume":"199","author":"Ghebrehiwet","year":"1998","journal-title":"Immunobiol"},{"key":"B8","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1242\/jcs.114.11.2115","article-title":"Retargeting of the mitochondrial protein p32\/gC1QR to a cytoplasmic compartment and the cell surface","volume":"114","author":"van Leeuwen","year":"2001","journal-title":"J Cell Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1006\/clin.1997.4374","article-title":"The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from activated cells: Subcellular distribution and immunochemical characterization","volume":"84","author":"Peterson","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.16966\/ijcrmm.110","article-title":"Soluble gC1qR in blood and body fluids: examination in a pancreatic cancer patient cohort","volume":"1","author":"Peerschke","year":"2015","journal-title":"Int J Cancer Res Molec Mech"},{"key":"B11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s004180000191","article-title":"Localization of p32 protein (gC1q-R) in mitochondria and at specific extramitochondrial locations in normal tissues","volume":"114","author":"Soltys","year":"2000","journal-title":"Histochem Cell Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"10784","DOI":"10.18632\/oncotarget.24082","article-title":"Multi-functional, multicompartmental hyaluronan-binding protein 1 (HABP1\/p32\/gC1qR): implication in cancer progression and metastasis","volume":"9","author":"Saha","year":"2018","journal-title":"Oncotarget"},{"key":"B13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/ijc.20105","article-title":"Receptor for the globular heads of C1q (gC1q-R, p33, hyaluronan-binding protein) is preferentially expressed by adenocarcinoma cells","volume":"110","author":"Rubinstein","year":"2004","journal-title":"Int J Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1369\/0022155412440882","article-title":"gC1qR expression in normal and pathologic human tissues: differential expression in tissues of epithelial and mesenchymal origin","volume":"60","author":"Dembitzer","year":"2012","journal-title":"J Histochem Cytochem"},{"key":"B15","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1349-7006.2010.01828.x","article-title":"Mitochondrial p32\/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate-specific antigen relapse time after radical prostatectomy","volume":"102","author":"Amamoto","year":"2011","journal-title":"Cancer Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/jso.21329","article-title":"Increased expression of hyaluronic acid binding protein 1 is correlated with poor prognosis in patients with breast cancer","volume":"100","author":"Chen","year":"2009","journal-title":"J Surg Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.yexmp.2012.06.007","article-title":"Significance of hyaluronan binding protein (HABP1\/P32\/gC1qR) expression in advanced serous ovarian cancer patients","volume":"94","author":"Yu","year":"2013","journal-title":"Exp Mol Pathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s13277-014-2761-8","article-title":"Overexpression of HABP1 correlated with clinicopathological characteristics and unfavorable prognosis in endometrial cancer","volume":"36","author":"Zhao","year":"2015","journal-title":"Tumour Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s10495-006-5396-4","article-title":"Upregulation of hyaluronan binding protein 1 (HABP1\/p32\/gC1qR) is associated with cisplatin induced apoptosis","volume":"11","author":"Kamal","year":"2006","journal-title":"Apoptosis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/CAD.0000000000000567","article-title":"The role of the globular heads of the C1q receptor in paclitaxel-induced human ovarian cancer cells apoptosis by a mitochondria-dependent pathway","volume":"29","author":"Lv","year":"2017","journal-title":"Anticancer Drugs"},{"key":"B21","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1126\/science.aao4555","article-title":"C1q restrains autoimmunity and viral infection by regulating CD8+ T cell metabolism","volume":"360","author":"Ling","year":"2018","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0090-1229(90)90014-H","article-title":"Interaction of C1q with its receptor on cultured cell lines induces an anti-proliferative response","volume":"54","author":"Ghebrehiwet","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1128\/JVI.78.12.6409-6419.2004","article-title":"Direct binding of hepatitis C virus core to gC1qR on CD4(+) and CD8(+) T cells leads to impaired activation of Lck and Akt","volume":"78","author":"Yao","year":"2004","journal-title":"J Virol"},{"key":"B24","first-page":"59","article-title":"C1q and C1q receptors (gC1qR and cC1qR) as potential novel targets for therapy against breast cancer","volume":"19","author":"Kandov","year":"2018","journal-title":"Curr Trends Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4161\/cc.10.23.18287","article-title":"The mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell death","volume":"23","author":"McGee","year":"2011","journal-title":"Cell Cycle"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1164\/ajrccm.157.5.9707141","article-title":"Mechanisms in the pathogenesis of asbestosis and silicosis","volume":"157","author":"Mossman","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1002\/cncr.28883","article-title":"Translational immunotherapeutics: chemoimmunotherapy for malignant pleural mesothelioma","volume":"120","author":"Adusumilli","year":"2014","journal-title":"Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1200\/JCO.2017.73.8401","article-title":"Long-term survival outcomes of cancer-directed surgery for malignant pleural mesothelioma: propensity score matching analysis","volume":"35","author":"Nelson","year":"2017","journal-title":"J Clin Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e1009285","DOI":"10.1080\/2162402X.2015.1009285","article-title":"The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: a comprehensive analysis reveals prognostic immune markers","volume":"4","author":"Ujiie","year":"2015","journal-title":"Oncoimmunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.21037\/atm.2017.03.82","article-title":"Extrapeural pneumonectomy (EPP) vs. pleurectomy decorication (P\/D)","volume":"5","author":"Batirel","year":"2017","journal-title":"Ann Transl Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"77872","DOI":"10.18632\/oncotarget.20845","article-title":"Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1","volume":"8","author":"Eguchi","year":"2017","journal-title":"Oncotarget"},{"volume-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart","year":"2015","key":"B34"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.humpath.2017.01.004","article-title":"Tumor-infiltrating lymphocytes are significantly associated with better overall survival and disease-free survival in triple-negative but not estrogen receptor-positive breast cancers","volume":"64","author":"Krishnamurti","year":"2017","journal-title":"Hum Pathol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00262-011-1073-8","article-title":"Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients","volume":"60","author":"Suzuki","year":"2011","journal-title":"Cancer Immunol. Immunother"},{"key":"B37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1089\/hyb.1996.15.333","article-title":"Identification of functional domains on gClQ-R, a cell surface protein that binds to the globular \u201cheads\u201d of C1Q, using monoclonal antibodies and synthetic peptides","volume":"15","author":"Ghebrehiwet","year":"1996","journal-title":"Hybridoma"},{"key":"B38","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/modpathol.2011.146","article-title":"A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma","volume":"25","author":"Kadota","year":"2012","journal-title":"Mod Pathol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1200\/JCO.2008.18.2808","article-title":"Ki67 expression and docetaxel efficacy in patients with estrogen receptor\u2013positive breast cancer","volume":"27","author":"Penault-Llorca","year":"2009","journal-title":"J Clin Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s10147-015-0897-1","article-title":"Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers","volume":"21","author":"Enomoto","year":"2016","journal-title":"Inter J Clin Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1470-2045(09)70262-1","article-title":"Ki67 in breast cancer: prognostic and predictive potential","volume":"11","author":"Yerushalmi","year":"2010","journal-title":"Lancet Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/bjc.2015.9","article-title":"Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study","volume":"112","author":"Ghanim","year":"2015","journal-title":"Brit J Cancer"},{"key":"B43","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.4049\/jimmunol.153.4.1430","article-title":"Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation","volume":"153","author":"Chen","year":"1994","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01559","article-title":"Complement protein C1q binds to hyaluronic acid in the malignant pleural mesothelioma microenvironment and promotes tumor growth","author":"Agostinis","year":"2017","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12931-017-0546-5","article-title":"CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives","volume":"18","author":"Cortes-Dericks","year":"2017","journal-title":"Respir Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.lungcan.2013.09.016","article-title":"Pleural effusion hyaluronic acid as a prognostic marker in pleural mesothelioma","volume":"82","author":"Creaney","year":"2013","journal-title":"Lung Cancer."},{"key":"B47","doi-asserted-by":"publisher","first-page":"d604","DOI":"10.2741\/A305","article-title":"The role of CD44 as a cell surface hyaluronan receptor during tumor invasion of connective tissue","volume":"3","author":"Knudson","year":"1998","journal-title":"Front Biosci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0161-5890(04)00076-8","article-title":"cC1qR (calreticulin) and gC1qR (p33): ubiquitously expressed multiligand binding cellular proteins involved in inflammation and infection","volume":"41","author":"Ghebrehiwet","year":"2004","journal-title":"Mol Immunol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01042\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T14:54:41Z","timestamp":1695308081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01042\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":48,"alternative-id":["10.3389\/fonc.2019.01042"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.01042","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2019,10,11]]},"article-number":"1042"}}